CD36 and posterior cortical atrophy: Significant metabolic differences between these subgroups would not only further justify the suitability of this technique for active surveillance of patients with low %GP4 disease, but also underpins the clinical utility of HP 13C-MRI for non-invasive metabolic risk-stratification of PCa.